← All Collegium Pharmaceutical, INC filings

Collegium Pharmaceutical, INC Form 4 insider transactions

NASDAQ
COLL
Collegium Pharmaceutical, INC
Form 4: Collegium Pharmaceutical EVP Thomas B. Smith Sells 995 Shares of Common Stock
EVP and Chief Medical Officer of Collegium Pharmaceutical, Thomas B. Smith, sold 995 shares of common stock at a price of $36.764 per share on February 29, 2024.
NASDAQ
COLL
Collegium Pharmaceutical, INC
Form 4: Collegium Pharmaceutical Executive Scott Dreyer Sells Shares Under 10b5-1 Plan
EVP & Chief Commercial Officer of Collegium Pharmaceutical, Scott Dreyer, sold shares of common stock on February 26, 2024, under a pre-arranged 10b5-1 trading plan.